DreaEJ: Transition of products from prescription to over the counter: The H2 antagonists. J Pharm PractV: 22–30, 1992.
3.
TanouyeE: Drug firms meet resistance on status changes. Wall Street J, October 22, 1993, pp 1–6.
4.
PartipiloMLWosterPS: The role of Heliocobacter pylori in peptic ulcer disease. The Michigan Drug Letter, Vol 12, No 2, 1993. The University of Michigan Medical Center, Dept of Pharmacy Services, Ann Arbor, MI.
5.
PartipiloMLWosterPS:The role of Helicobacter pylori in peptic ulcer disease. Pharmacotherapy13:330–339, 1993.
6.
LewisJH: A Pharmacologic Approach to Gastrointestinal Disorders. Baltimore, MD, Williams and Wilkins, 1993.